Primary Record
Sitagliptin
- In stock
- 5,714 g
- Purity
- 98.8 %
- CAS
- 486460-32-6
Compound Identifiers & Properties
- CAS
- 486460-32-6
- PubChem CID
- 4369359
- SMILES
- C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N
- Canonical SMILES
- N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F
Names & Synonyms
- Sitagliptin
- Januvia
- 486460-32-6
- Xelevia
- Zituvio
- sitagliptina
- sitagliptine
- Sitagliptan
- sitagliptinum
- Janumet
- Sitagliptin phosphate
- Tesavel
- mine
- ristaben
- Sitagliptin Base
- Stotigliptin
- rac-Sitagliptin
- Sitagliptin/
- Sitagliptin [INN]
- Januvia (TN)
- Sitagliptin (13)
- SitagliptinMK0431
- Januvia (merck & Co.)
- MK-0431
- QFP0P1DV7Z
- LEZ763
- Sitagliptin/atovastatin
- UNII-QFP0P1DV7Z
- RefChem:6227
- Tube110
- Sitagliptin Hydrochloride
- Sitagliptin; MK0431
- (-)-(R)-Sitagliptin
- AC1N9ZYR
- Sitagliptin (Prop.INN)
- Sitagliptin [INN:BAN]
- SITAGLIPTIN [MI]
- Sitagliptin (USAN/INN)
- SITAGLIPTIN [HSDB]
- SITAGLIPTIN [USAN]
- C16H15F6N5O
- D0P0HH
- D0U2JP
- SITAGLIPTIN [VANDF]
- LEZ-763
- CHEMBL1422
- Sitagliptin phosphate hydrate
- MFCD09838015
- SCHEMBL17783
- BSPBio_002262
- SITAGLIPTIN [WHO-DD]
- Sitagliptin phosphate monohydrate
- Triazolopiperazine Analogue 1
- CHEBI:40237
- HSDB 7516
- MLS006011959
- sitagliptin phosphate anhydrous
- DTXSID70197572
- LEZ 763
- MFFMDFFZMYYVKS-SECBINFHSA-N
- SITAGLIPTIN [EMA EPAR]
- Sitagliptin [USAN:INN:BAN]
- CHEMBL393336
- GTPL6286
- orb1310801
- Sitagliptin (Metformin,MK-0431)
- SCHEMBL29365085
- BDBM11162
- ERK5-2I04
- AMY6930
- DTXCID30120063
- 1x70
- (R)-3-AMINO-1-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL)-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE
- GLXC-15213
- HMS2093F20
- ZITUVIMET COMPONENT SITAGLIPTIN
- ACT02665
- AMX10120
- EX-A2816
- MK 0431
- MSK11067
- sitagliptin monophosphate monohydrate
- WHO 8692
- ZINC1489478
- ABP000233
- AN-404
- BBF-05866
- EBC-13573
- NSC813215
- AKOS015888724
- ACN-037559
- CB10244
- CCG-268731
- CID4369359
- CS-2914
- CS-O-31560
- DB01261
- FA31666
- NSC-813215
- RL03803
- NCGC00178734-03
- NCGC00178734-06
- NCGC00178734-13
- (3R)-3-AMINO-1-[3-(TRIFLUOROMETHYL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE
- AJ-26333
- AS-19118
- HY-13749
- SC-19743
- SMR002546724
- EC 690-730-1
- SBI-0206871.P001
- Sitagliptin 100 microg/mL in Acetonitrile
- AB0006583
- AB1004599
- LS-187389
- 2201B
- A4036
- C16-H15-F6-N5-O.H3-O4-P
- FT-0650740
- FT-0674600
- FT-0693933
- NS00000425
- S5079
- X4663
- (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
- J2.231.708C
- A14377
- A25516
- D08516
- EN300-119510
- Q-1665
- AB01563393_01
- AR-270/43507782
- F358083
- Q419832
- SR-05000001748
- (2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE
- (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
- 790712-60-6
- SR-05000001748-1
- BRD-K19416115-001-01-2
- BRD-K19416115-001-03-8
- BRD-K19416115-001-05-3
- BRD-K19416115-366-02-7
- 1,2,4-Triazolo[4,3-a]pyrazine,7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-
- Z1521553713
- (3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
- (2R)-4-OXO-4-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO(1,2,4)TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE
- 1,2,4-Triazolo(4,3-a)pyrazine, 7-((3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl)-5,6,7,8-tetrahydor-3-(trifluoromethyl)-
- 654671-77-9
- 7-((3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)buyl)-5,6,7,8-tetrahydro-3-trifluoromethyl)-1,4-triazolo(4,3-a)
- 7-[(3r)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine
- (1R)-3-oxo-3-[3-(trifluoroethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorobenzyl)propylamine
- (2R)-4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate salt
- (2r)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a] pyrazin-7(8h)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine
- (2r)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8h)-yl]-1-(2,4,5-trifluorophenyl)butan-2-a
- (2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-A MINE
- (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-alpha]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine
- (3R)-1-[3-(Trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-3-amino-4-(2,4,5-trifluorophenyl)-1-butanone
- (3R)-1-[3-(Trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-3-amino-4-(2,4,5-trifluorophenyl)butan-1-one
- (3R)-3-AMINO-1-(3-(TRIFLUOROMETHYL)-5,6,7,8-TETRAHYDRO-1,2,4-TRIAZOLO(4,3-A)PYRAZIN-7-YL)-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE
- (3R)-3-amino-1-(3-(trifluoromethyl)-5H,6H,7H,8H-(1,2,4)triazolo(4,3-a)pyrazin-7-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
- (3R)-3-amino-1-(3-(trifluoromethyl)-6,8-dihydro-5H-(1,2,4)triazolo(4,3-a)pyrazin-7-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
- (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6-dihydro-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
- (3R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[3,4-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one hydrochloride
- (3R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;(R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
- (R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine
- (S)-3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
- 1,2,4-TRIAZOLO(4,3-A)PYRAZINE-7(8H)-PROPANAMINE, 5,6-DIHYDRO-.GAMMA.-OXO-3-(TRIFLUOROMETHYL)-.ALPHA.-((2,4,5-TRIFLUOROPHENYL)METHYL)-, (.ALPHA.R)-
- 1,2,4-Triazolo[4,3-a]pyrazine, 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)- (9CI); (2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine; 3(R)-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; Sitagliptin, 1-Butanone, 3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (3R)-
- 1169707-31-6
- 3-oxo-1-(2,4,5-trifluorobenzyl)-3-(3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)propylamine
- 4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine
- 690-730-1
- 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)buyl]-5,6,7,8-tetrahydro-3-trifluoromethyl)-1,4-triazolo[4,3-a]
- 823817-56-7